CYTOMED THERAPEUTICS stock price
사이토메드 테라퓨틱스NASDAQ:GDTC · Nasdaq · Healthcare$0.9200+2.23%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →CYTOMED THERAPEUTICS last closed at $0.9200 (+2.23%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is -2.2×. Its overall grade ranks 688 of 739 stocks in Healthcare.
About this company
CYTOMED THERAPEUTICS last closed at $0.9200 (+2.23%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 688/739
Valuation grade C+
Related stocks
- AstraZenecaCustomer
세포·유전자치료제 분야의 잠재적 기술협력 및 상업화 파트너
- NovartisCustomer
세포치료·유전자치료제 개발 경쟁 및 라이선스/협력 대상
- Bristol-Myers SquibbCustomer
면역항암·세포치료제 영역의 주요 제약사이자 협력/인수 가능 파트너
About CYTOMED THERAPEUTICS
- What technical signals does CYTOMED THERAPEUTICS (GDTC) have?
- CYTOMED THERAPEUTICS current technical signals: no active technical signal.
- Is CYTOMED THERAPEUTICS a cup-and-handle pattern?
- No. CYTOMED THERAPEUTICS has no valid Cup signal right now.
- What published figures are available for CYTOMED THERAPEUTICS?
- Trailing 12 months PER: -2.2×. Latest quarter PBR: 1.58×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about CYTOMED THERAPEUTICS, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy